Cargando…
TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma
Exosome DNA (exoDNA) can be used for liquid biopsy. This study was the first to use droplet digital PCR (ddPCR) to detect tumor-specific mutations in exoDNA and to evaluate the prognosis of hepatocellular carcinoma (HCC) patients. 60 HCC patients were enrolled in the study. We used ddPCR to detect c...
Autores principales: | Li, Yong, Wu, Junjun, Li, Enliang, Xiao, Zhouqing, Lei, Jun, Zhou, Fan, Yin, Xiangbao, Hu, Dandan, Mao, Yilei, Wu, Linquan, Wenjun, Liao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354767/ https://www.ncbi.nlm.nih.gov/pubmed/35921289 http://dx.doi.org/10.1080/15384047.2022.2094666 |
Ejemplares similares
-
The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma: A meta-analysis
por: Sun, Chi, et al.
Publicado: (2017) -
TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a
por: Liu, Weiwei, et al.
Publicado: (2021) -
Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends
por: Wang, Jiakun, et al.
Publicado: (2019) -
Application of VR and 3D printing in liver reconstruction
por: Yang, Jun, et al.
Publicado: (2022) -
Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
por: Li, Xuerui, et al.
Publicado: (2020)